The findings presented here suggest that while IL‐6 produced by adipose tissue is associated with obesity, systemic levels of IL‐6 may be associated with weight loss and improved insulin sensitivity early after VSG‐induced weight loss. The gene discussed is IL6; the disease is obesity disorder.